Barclays raised the firm’s price target on Walgreens Boots Alliance to $8 from $7 and keeps an Underweight rating on the shares. The company’s Q4 report brought better than feared fiscal 2025 guidance and data points that help alleviate near term liquidity concerns, the analyst tells investors in a research note. However, the firm says its structural concerns on U.S. retail pharmacy persist.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Walgreens Boots Alliance Inc. Earnings Update: Did it Beat Estimate Forecasts?
- Walgreens Boots Alliance price target raised to $10 from $7.50 at Evercore ISI
- Walgreens Stock (NASDAQ:WBA) Soars as It Plans Mass Store Closures
- Big banks, UnitedHealth report quarterly earnings: Morning Buzz
- Walgreens sees closing about 1,200 store over next three years